Pitolisant long term effect in sleepy obstructive sleep apnea patients without CPAP.
Y. Dauvilliers (Montpellier, France), J. Verbraecken (ANtwerp, Belgium), M. Partinen (Helsinki, Finland), J. Hedner (Göteborg, Sweden), T. Saaresranta (Turku, Finland), O. Georgiev (Sofia, Bulgaria), R. Tiholov (Kozloduy, Bulgaria), C. Caussé (Paris, France), I. Lecomte (Paris, France), R. Tamisier (Grenoble, France), P. Lévy (Grenoble, France), J. Lecomte (Paris, France), J. Schwartz (Paris, France), J. Pépin (Grenoble, France)
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Dauvilliers (Montpellier, France), J. Verbraecken (ANtwerp, Belgium), M. Partinen (Helsinki, Finland), J. Hedner (Göteborg, Sweden), T. Saaresranta (Turku, Finland), O. Georgiev (Sofia, Bulgaria), R. Tiholov (Kozloduy, Bulgaria), C. Caussé (Paris, France), I. Lecomte (Paris, France), R. Tamisier (Grenoble, France), P. Lévy (Grenoble, France), J. Lecomte (Paris, France), J. Schwartz (Paris, France), J. Pépin (Grenoble, France). Pitolisant long term effect in sleepy obstructive sleep apnea patients without CPAP.. 745
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Pitolisant long term effect in sleepy obstructive sleep apnea patients without CPAP Source: Sleep and Breathing Conference 2021 Year: 2021
Pitolisant long term effect in sleepy obstructive sleep apnea patients with CPAP Source: Sleep and Breathing Conference 2021 Year: 2021
CPAP variability in long term follow-up of OSAS (obstructive sleep apnea syndrome) patients Source: Eur Respir J 2006; 28: Suppl. 50, 412s Year: 2006
Effects of long term nCPAP treatment on patients with obstructive sleep apnoea syndrom Source: Eur Respir J 2007; 30: Suppl. 51, 322s Year: 2007
CPAP treatment for obstructive sleep apnoea syndrome after CPAP training term Source: Eur Respir J 2002; 20: Suppl. 38, 102s Year: 2002
Auto-titrating CPAP for treating obstructive sleep apnoea, a bimodal response in males? Source: Eur Respir J 2006; 28: Suppl. 50, 409s Year: 2006
Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients? Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006
Does personality change in obstructive sleep apnea (OSA) patients using CPAP? Source: Eur Respir J 2006; 28: Suppl. 50, 409s Year: 2006
Return of sleep apnoea and sleep fragmentation following CPAP withdrawal in patients with obstructive sleep apnoea Source: Eur Respir J, 53 (5) 1802351; 10.1183/13993003.02351-2018 Year: 2019
The effect of CPAP treatment on Galectin-3 level in patients with severe obstructive sleep apnea Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018
Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009
PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012
Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea Year: 2006
Hypercapnia and respiratory drive in obstructive sleep apnoea patients before and after CPAP treatment Source: Eur Respir J 2002; 20: Suppl. 38, 103s Year: 2002
Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019
Reported but not measured sleep latency predicts successful CPAP therapy in patients with obstructive sleep apnoea Source: Eur Respir J 2002; 20: Suppl. 38, 101s Year: 2002
Wrist-actigraphic estimation of sleep time under nCPAP treatment in sleep apnoea patients Source: Eur Respir J 2004; 23: 891-895 Year: 2004
The effect of theophylline and CPAP on cytokine release in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006
Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 97s Year: 2003
Long-term CPAP compliance in women with obstructive sleep apnoea Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012